Top

Published in:

Open Access 01-06-2012 | Original Communication

Deficient sustained attention to response task and P300 characteristics in early Huntington’s disease

Authors: E. P. Hart, E. M. Dumas, R. H. A. M. Reijntjes, K. van der Hiele, S. J. A. van den Bogaard, H. A. M. Middelkoop, R. A. C. Roos, J. G. van Dijk

Published in: Journal of Neurology | Issue 6/2012

Abstract

Evidence for the extent and nature of attentional impairment in premanifest and manifest Huntington’s disease (HD) is inconsistent. Understanding such impairments may help to better understand early functional changes in HD and could have consequences concerning care for HD patients. We investigated attentional control in both early and premanifest HD. We studied 17 early HD subjects (mean age: 51 years), 12 premanifest HD subjects (mean age: 43 years), and 15 healthy controls (mean age: 51 years), using the sustained attention to response task (SART), a simple Go/No-go test reflecting attentional and inhibitory processes through reaction time (RT) and error rates. Simultaneously recorded EEG yielded P300 amplitudes and latencies. The early HD group made more Go errors (p < 0.001) and reacted slower (p < 0.005) than the other groups. The RT pattern during the SART was remarkably different for early HD subjects compared to the other two groups (p < 0.005), apparent as significant post-error slowing. P300 data showed that for early HD the No-go amplitude was lower than for the other two groups (p < 0.05). Subjects with early HD showed a reduced capacity to effectively control attention. They proved unable to resume the task directly after having made an error, and need more time to return to pre-error performance levels. No attentional control deficits were found for the premanifest HD group.

Aron AR, Schlaghecken F, Fletcher PC, Bullmore ET, Eimer M, Barker R, Sahakian BJ, Robbins TW (2003) Inhibition of subliminally primed responses is mediated by the caudate and thalamus: evidence from functional MRI and Huntington’s disease. Brain 126:713–723PubMedCrossRef

Aron AR, Watkins L, Sahakian BJ, Monsell S, Barker RA, Robbins TW (2003) Task-set switching deficits in early-stage Huntington’s disease: implications for basal ganglia function. J Cogn Neurosci 15:629–642PubMedCrossRef

Bellgrove MA, Hawi Z, Gill M, Robertson IH (2006) The cognitive genetics of attention deficit hyperactivity disorder (ADHD): sustained attention as a candidate phenotype. Cortex 42:838–845PubMedCrossRef

Beste C, Saft C, Andrich J, Gold R, Falkenstein M (2008) Response inhibition in Huntington’s disease––a study using ERPs and sLORETA. Neuropsychologia 46:1290–1297PubMedCrossRef

Beste C, Willemssen R, Saft C, Falkenstein M (2010) Response inhibition subprocesses and dopaminergic pathways: basal ganglia disease effects. Neuropsychologia 48:366–373PubMedCrossRef

Chan RC (2001) A further study on the sustained attention response to task (SART): the effect of age, gender and education. Brain Inj 15:819–829PubMedCrossRef

Chan RC, Chen EY, Cheung EF, Chen RY, Cheung HK (2004) A study of sensitivity of the sustained attention to response task in patients with schizophrenia. Clin Neuropsychol 18:114–121PubMedCrossRef

Couette M, Bachoud-Levi AC, Brugieres P, Sieroff E, Bartolomeo P (2008) Orienting of spatial attention in Huntington’s Disease. Neuropsychologia 46:1391–1400PubMedCrossRef

Craufurd D, Thompson JC, Snowden JS (2001) Behavioural changes in Huntington Disease. Neuropsychiatry Neuropsychol Behav Neurol 14:219–226PubMed

10.

Craufurd D, Thompson JC, Snowden JS (2001) Behavioral changes in Huntington Disease. Neuropsychiatry Neuropsychol Behav Neurol 14:219–226PubMed

11.

Datta A, Cusack R, Hawkins K, Heutink J, Rorden C, Robertson IH, Manly T (2007) The p300 as a marker of waning attention and error propensity. Comput Intell Neurosci 93968

12.

de Tommaso M, Sciruicchio V, Specchio N, Difruscolo O, Vitale C, Specchio LM, Puca F (2003) Early modifications of auditory event-related potentials in carriers of the Huntington’s disease gene. Acta Neurol Belg 103:192–198PubMed

13.

Dumas EM, van den Bogaard SJ, Ruber ME, Reilman RR, Stout JC, Craufurd D, Hicks SL, Kennard C, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA (2011) Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington’s disease. Hum Brain Mapp. doi:10.1002/hbm.2120510.1002/hbm.21205

14.

Duncan CC, Barry RJ, Connolly JF, Fischer C, Michie PT, Naatanen R, Polich J, Reinvang I, Van PC (2009) Event-related potentials in clinical research: guidelines for eliciting, recording, and quantifying mismatch negativity, P300 and N400. Clin Neurophysiol 120:1883–1908PubMedCrossRef

15.

Fronczek R, Middelkoop HA, van Dijk JG, Lammers GJ (2006) Focusing on vigilance instead of sleepiness in the assessment of narcolepsy: high sensitivity of the Sustained Attention to Response Task (SART). Sleep 29:187–191PubMed

16.

Giordani B, Berent S, Boivin MJ, Penney JB, Lehtinen S, Markel DS, Hollingsworth Z, Butterbaugh G, Hichwa RD, Gusella JF (1995) Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington’s disease. Arch Neurol 52:59–64PubMedCrossRef

17.

HDCRG (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group. Cell 72:971–983CrossRef

18.

Helton WS, Kern RP, Walker DR (2009) Conscious thought and the sustained attention to response task. Conscious Cogn 18:600–607PubMedCrossRef

19.

Homberg V, Hefter H, Granseyer G, Strauss W, Lange H, Hennerici M (1986) Event-related potentials in patients with Huntington’s disease and relatives at risk in relation to detailed psychometry. Electroencephalogr Clin Neurophysiol 63:552–569PubMedCrossRef

20.

Hopfinger JB, Buonocore MH, Mangun GR (2000) The neural mechanisms of top-down attentional control. Nat Neurosci 3:284–291PubMedCrossRef

21.

Jurgens CK, van der Hiele K, Reijntjes RH, van de Wiel L, Witjes-Ane MN, van der Grond J, Roos RA, Middelkoop HA, van Dijk JG (2011) Basal ganglia volume is strongly related to P3 event-related potential in premanifest Huntington’s disease. Eur J Neurol 18:1105–1108PubMedCrossRef

22.

Kok A (1997) Event-related-potential (ERP) reflections of mental resources: a review and synthesis. Biol Psychol 45:19–56PubMedCrossRef

23.

Lawrence AD, Hodges JR, Rosser AE, Kershaw A, ffrench-Constant C, Rubinsztein DC, Robbins TW, Sahakian BJ (1998) Evidence for specific cognitive deficits in preclinical Huntington’s disease. Brain 121(Pt 7):1329–1341PubMedCrossRef

24.

Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R (2004) Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation––a longitudinal follow-up study. J Neurol 251:935–942PubMedCrossRef

25.

Luck SJ (2005) An introduction to the event-related potential technique. The MIT Press, London, England

26.

Milham MP, Erickson KI, Banich MT, Kramer AF, Webb A, Wszalek T, Cohen NJ (2002) Attentional control in the aging brain: insights from an fMRI study of the stroop task. Brain Cogn 49:277–296PubMedCrossRef

27.

Muller SV, Jung A, Preinfalk J, Kolbe H, Ridao-Alonso M, Dengler R, Munte TF (2002) Disturbance of “extrinsic alertness” in Huntington’s disease. J Clin Exp Neuropsychol 24:517–526PubMedCrossRef

28.

Munte TF, Ridao-Alonso ME, Preinfalk J, Jung A, Wieringa BM, Matzke M, Dengler R, Johannes S (1997) An electrophysiological analysis of altered cognitive functions in Huntington disease. Arch Neurol 54:1089–1098PubMedCrossRef

29.

Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington’s disease. Ann Neurol 41:689–692PubMedCrossRef

30.

Polich J, Criado JR (2006) Neuropsychology and neuropharmacology of P3a and P3b. Int J Psychophysiol 60:172–185PubMedCrossRef

31.

Robertson IH, Manly T, Andrade J, Baddeley BT, Yiend J (1997) ‘Oops!’: performance correlates of everyday attentional failures in traumatic brain injured and normal subjects. Neuropsychologia 35:747–758PubMedCrossRef

32.

Roman MJ, Delis DC, Filoteo JV, Demadura TL, Paulsen J, Swerdlow NR, Swenson MR, Salmon D, Butters N, Shults C (1998) Is there a “subcortical” profile of attentional dysfunction? A comparison of patients with Huntington’s and Parkinson’s diseases on a global-local focused attention task. J Clin Exp Neuropsychol 20:873–884PubMedCrossRef

33.

Samavatyan H, Leth-Steensen C (2009) The time course of task switching: a speed-accuracy trade-off analysis. Mem Cognit 37:1051–1058PubMedCrossRef

34.

Shoulson I, Fahn S (1979) Huntington disease: clinical care and evaluation. Neurology 29:1–3PubMedCrossRef

35.

Smilek D, Carriere JS, Cheyne JA (2010) Failures of sustained attention in life, lab, and brain: ecological validity of the SART. Neuropsychologia 48:2564–2570PubMedCrossRef

36.

Sprengelmeyer R, Lange H, Homberg V (1995) The pattern of attentional deficits in Huntington’s disease. Brain 118(Pt 1):145–152PubMedCrossRef

37.

Sterr A (2006) Preparing not to move: does no-response priming affect advance movement preparation processes in a response priming task? Biol Psychol 72:154–159PubMedCrossRef

38.

Stout JC, Weaver M, Solomon AC, Queller S, Hui S, Johnson SA, Gray J, Beristain X, Wojcieszek J, Foroud T (2007) Are cognitive changes progressive in prediagnostic HD? Cogn Behav Neurol 20:212–218PubMedCrossRef

39.

Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC (2011) Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10:31–42PubMedCrossRef

40.

UHDRS (1996) Unified Huntington’s disease rating scale: reliability and consistency. Huntington study group. Mov Disord 11:136–142CrossRef

41.

van den Bogaard SJ, Dumas EM, Acharya TP, Johnson H, Langbehn DR, Scahill RI, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA (2010) Early atrophy of pallidum and accumbens nucleus in Huntington’s disease. J Neurol 258(3):412–420

42.

Witjes-Ane MN, Vegter-van der Vlis M, van Vugt JP, Lanser JB, Hermans J, Zwinderman AH, van Ommen GJ, Roos RA (2003) Cognitive and motor functioning in gene carriers for Huntington’s disease: a baseline study. J Neuropsychiatry Clin Neurosci 15:7–16PubMedCrossRef

Title: Deficient sustained attention to response task and P300 characteristics in early Huntington’s disease
Authors: E. P. Hart
E. M. Dumas
R. H. A. M. Reijntjes
K. van der Hiele
S. J. A. van den Bogaard
H. A. M. Middelkoop
R. A. C. Roos
J. G. van Dijk
Publication date: 01-06-2012
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 6/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-011-6334-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Deficient sustained attention to response task and P300 characteristics in early Huntington’s disease

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2012

The hemodynamic status within 24 h after intravenous thrombolysis predicts infarct growth in acute ischemic stroke

The pulvinar sign in Fabry patients: the first report in female patients

Charles-Prosper Ollivier d’Angers (1796–1845)

Guillain–Barré syndrome associated with normal or exaggerated tendon reflexes

PINK1: pumps, paraesthesia, punding and psychosis

Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis